FAST NEWS: Simcere Pharma Posts 94% Profit Decline Amid Investment Portfolio Impairment
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) issued a profit warning on Monday, estimating a net profit of 34 million yuan ($50 million) to 94 million yuan for the six months…
RELATED ARTICLES
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK - Cancer drug maker Genfleet joins Hong Kong IPO influx
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
-
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK ONC.US 688235.SHG
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
- Innogen Pharma jostles for a slice of the weight-loss market
